{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:10:01Z","timestamp":1792624201727,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":3083,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003099","name":"FAZIT Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ajpath.2012.08.033","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T01:15:53Z","timestamp":1349658953000},"page":"2161-2171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile"],"prefix":"10.1016","volume":"181","author":[{"given":"Corinna","family":"Preu\u00dfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephin","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Wengert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Scheibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Irlbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.08.033_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00415-003-1027-y","article-title":"Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy","volume":"250","author":"Bronner","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0b013e32834b324b","article-title":"Necrotizing autoimmune myopathy","volume":"23","author":"Liang","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"Dalakas","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajpath.2012.08.033_bib6","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.lpm.2010.11.023","article-title":"Myositis or dystrophy?","volume":"40","author":"Benveniste","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.ajpath.2012.08.033_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11940-011-0119-8","article-title":"Immunotherapy of inflammatory myopathies: practical approach and future prospects","volume":"13","author":"Dalakas","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WCO.0b013e32834a9589","article-title":"Inflammatory myopathies: management of steroid resistance","volume":"24","author":"Dalakas","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"Pt 6","key":"10.1016\/j.ajpath.2012.08.033_bib9","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2012.08.033_bib10","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib11","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib12","first-page":"410","article-title":"Dermatomyositis and polymyositis: new treatment targets on the horizon","volume":"69","author":"Hak","year":"2011","journal-title":"Neth J Med"},{"key":"10.1016\/j.ajpath.2012.08.033_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2008-1062267","article-title":"Inflammatory myopathies: evaluation and management","volume":"28","author":"Greenberg","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/kep355","article-title":"Re-classifying myositis","volume":"49","author":"Sultan","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rdc.2011.01.001","article-title":"Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features","volume":"37","author":"Khan","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ajpath.2012.08.033_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp.2008.168294","article-title":"Toxic and drug-induced myopathies","volume":"80","author":"Dalakas","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajpath.2012.08.033_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.10313","article-title":"Inflammatory myopathies: clinical, diagnostic and therapeutic aspects","volume":"27","author":"Mastaglia","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.08.033_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase (HMGCR) in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajpath.2012.08.033_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.08.033_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/CND.0b013e31815e5d4a","article-title":"Steroid-responsive myopathy: immune-mediated necrotizing myopathy or polymyositis without inflammation?","volume":"9","author":"Sadeh","year":"2008","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ajpath.2012.08.033_bib22","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.08.033_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis","volume":"1184","author":"Mammen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajpath.2012.08.033_bib26","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpath.2012.08.033_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib30","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2169\/internalmedicine.44.527","article-title":"Autoantibodies to aminoacyl-tRNA synthetases","volume":"44","author":"Hirakata","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.ajpath.2012.08.033_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.41.6.936","article-title":"Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration","volume":"41","author":"Emslie-Smith","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nmd.2007.01.004","article-title":"Paraneoplastic myopathy: response to intravenous immunoglobulin","volume":"17","author":"Sampson","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.08.033_bib34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","article-title":"Paraneoplastic necrotizing myopathy: clinical and pathological features","volume":"50","author":"Levin","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncprheum0760","article-title":"Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis","volume":"4","author":"Suber","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-011-0232-9","article-title":"Update on toxic myopathies","volume":"12","author":"Mastaglia","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ajpath.2012.08.033_bib37","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ajpath.2010.11.065","article-title":"M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis","volume":"178","author":"Prokop","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","article-title":"Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology","volume":"35","author":"Dimitri","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.08.033_bib39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/WNL.54.5.1033","article-title":"AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis","volume":"54","author":"Banwell","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","article-title":"Cytokine expression profile in idiopathic inflammatory myopathies","volume":"55","author":"Tews","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/rheumatology\/keh079","article-title":"Refractory polymyositis responding to infliximab: extended follow-up","volume":"43","author":"Labioche","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.ajpath.2012.08.033_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003643.pub2","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Choy","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajpath.2012.08.033_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4049\/jimmunol.166.1.650","article-title":"Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients","volume":"166","author":"Shi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib44","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2008.04.025","article-title":"Lymphoid chemokines in chronic neuroinflammation","volume":"198","author":"Aloisi","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.08.033_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0710409","article-title":"Obstacles and opportunities for understanding macrophage polarization","volume":"89","author":"Murray","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib50","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib51","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2012.08.033_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/s10165-008-0139-8","article-title":"Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies","volume":"19","author":"Takada","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatibility complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0022-510X(89)90023-3","article-title":"Expression of class I and class II MHC antigens in neuromuscular diseases","volume":"89","author":"McDouall","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ajpath.2012.08.033_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000308714","article-title":"Paraneoplastic necrotizing myopathy with a mild inflammatory component: a case report and review of the literature","volume":"3","author":"Wegener","year":"2010","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.08.033_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2012.08.033_bib59","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199103283241303","article-title":"Polymyositis mediated by T lymphocytes that express the gamma\/delta receptor","volume":"324","author":"Hohlfeld","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2012.08.033_bib60","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1212\/01.wnl.0000279589.06059.37","article-title":"Revisiting the immunopathogenesis of the inflammatory myopathies","volume":"69","author":"Hohlfeld","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","article-title":"Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells","volume":"50","author":"Page","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9440(10)63131-8","article-title":"Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression","volume":"164","author":"Page","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(96)00280-8","article-title":"Expression of tumor necrosis factor-alpha in muscles of polymyositis","volume":"146","author":"Tateyama","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ajpath.2012.08.033_bib64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.1995.tb03587.x","article-title":"Local T-cell proliferation and differentiation in inflammatory myopathies","volume":"41","author":"Lindberg","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051165","article-title":"Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis","volume":"99","author":"Kuru","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-8966(98)00126-6","article-title":"Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies","volume":"9","author":"De Bleecker","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.08.033_bib68","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2990.1998.00092.x","article-title":"Local expression of cytokines in idiopathic inflammatory myopathies","volume":"24","author":"Lepidi","year":"1998","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib70","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"Greenberg","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2012.08.033_bib71","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib72","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib74","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis","volume":"60","author":"Lopez De Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.08.033_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)","volume":"16","author":"Arlet","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2012.08.033_bib77","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies: a report of 4 cases and review of the literature","volume":"27","author":"Rios Fernandez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib78","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/rheumatology\/kep027","article-title":"Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion","volume":"48","author":"Whelan","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib79","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome: a retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, classification and treatment of inflammatory myopathies","volume":"7","author":"Zong","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib81","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajpath.2012.08.033_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","article-title":"Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up","volume":"52","author":"Hengstman","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ajpath.2012.08.033_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401200675X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401200675X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:03:15Z","timestamp":1762081395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401200675X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S000294401200675X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.033","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}